APUS
Apimeds Pharmaceuticals US, Inc. (AMEX)
Healthcare — Drug Manufacturers - Specialty & Generic
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
None
$0.65
+$0.01 (+1.95%)
Sign in to add APUS to a watchlist or set price alerts.
Price History
Fundamentals
| Market Cap | $13.28M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-2.78 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 29.9 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | - |
| 52-Week Low | - |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | 192.2K |
| Volume | 19.6K |
Performance Analysis
NEUTRALAPUS presents a mixed picture with both positive and negative indicators.
+
RSI at 29.9 signals oversold conditions — a bounce may be ahead.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 01, 2026 15:01 UTC
Back to Screener Export Report